Skin Cancer Clinical Trial
Official title:
3D Printed Rigid Bolus Versus Silicone Bolus: A Comparative Study
This study compares two types of 3D-printed skin bolus (rigid and flexible) used to optimize the treatment of tumors/cancers involving the skin. Each patient will have both types of bolus made, with each will be used on alternating days. The goal is to determine if one type of bolus provides a better fit and thus radiotherapy plan, the ease of use of each type of bolus, and patient reported feedback.
Need for Skin Bolus during Radiotherapy for Cancers that Involve the Skin Using standard megavoltage (MV) radiotherapy to treat tumors that involve the skin is technically challenging as without modification, the high-energy radiotherapy machines under-dose the superficial tissue. This is a problem, as this may lead to an inadequate radiation dose being delivered to the skin, thus compromising tumor control. To compensate for this, a flexible polymer material ("bolus") measuring 5-10mm in thickness is placed over the skin during radiotherapy. There are many types of boluses used internationally from rubber to candle wax slabs. The bolus allows the radiation dose to build up so that a sufficient dose is deposited at the skin. Use of bolus for cancers involving the skin is considered the standard of care when using conventional MV radiotherapy. Challenges of Using Conventional Bolus Many standard boluses are slightly flexible, but are not able to follow significant changes in the underlying contours. When a bolus is not able to follow an individual's unique 'peaks and valleys' in contour, it can lead to air gaps between the bolus and the skin. An air gap, which is easily seen during imaging, can also vary on a day-to-day basis due to slight changes in positioning of the bolus prior to radiotherapy treatment. The varying air gaps can affect how much radiation dose is getting to the skin, and can potentially lead to under-dosing of the cancer cells in the skin. Even small air gaps (i.e. 5mm in thickness), can cause a 5% error in dose, which exceeds the safe tolerance for treatment. Areas where this can be a problem are where the patient's anatomy undergoes significant topographical changes in a small area. Examples of this include the ear, nose, top of head. Patients with metastatic cancer can also have large lymph nodes or masses that are growing towards the skin that can be difficult to accommodate with standard bolus materials. 3D-Printed Bolus One method to overcome challenging anatomy for cases that require skin bolus for radiotherapy is the use of 3D-printed bolus. This technology uses data acquired from a CT scan of the affected area. The patients contour can then be used to create an individualized bolus that matches the patient contour for the treatment field. This technology has been demonstrated to improve fit (less air gaps) and decreased radiotherapy treatment time. The bolus used in this study was rigid. Trial design and Rationale Other than the chestwall study, the literature on 3D-printed bolus for radiotherapy has focused on the dosimetry and feasibility of using this technology. However, it is used in an ad hoc method in many centers, using various workflows. There are no studies examining which type of bolus provides the best radiotherapy plan, is the easiest to use at the radiation therapy machines or which is preferred by patients. To fill this gap, this study will aim to answer a few questions. It will compare the use of rigid 3D-printed bolus (most commonly used and reported in the literature) versus a flexible silicone 3D-printed bolus. Both types of bolus will be used to treat patients with cancers involving the skin. This will allow comparison of radiotherapy plans for each patient between the two types of bolus where each subject is his/her own control. The study will also collect data about real-time set-up using each bolus and feedback from radiation therapists (deliver radiation treatments) about the ease of use of each. Lastly, patients will complete a short survey to provide feedback about comfort with use of each type of bolus and to determine if one type of bolus is favored over the other. This data will be instrumental is determining the standard of care of the use of 3D-printed bolus as it will assess two types of bolus in three domains: ability to help generate an adequate radiotherapy plan, ease of use by the specialists that deliver the radiotherapy (radiation therapists) and patient reported feedback. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02721459 -
XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma
|
Phase 1 | |
Completed |
NCT03740815 -
Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection
|
N/A | |
Recruiting |
NCT05779423 -
Cryoablation+Ipilimumab+Nivolumab in Melanoma
|
Phase 2 | |
Terminated |
NCT01468818 -
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma
|
Phase 2 | |
Completed |
NCT01820234 -
Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event
|
N/A | |
Completed |
NCT00535769 -
Evaluation of Adherence to Topical Agents: Applying Communication Technology to Improve Sunscreen Use
|
Phase 0 | |
Completed |
NCT00526032 -
Melanoma Detection by Oblique-Incidence Optical Spectroscopy
|
N/A | |
Completed |
NCT00588341 -
Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection
|
Phase 2 | |
Active, not recruiting |
NCT01447199 -
The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
|
||
Enrolling by invitation |
NCT04758988 -
AI Augmented Training for Skin Specialists
|
N/A | |
Not yet recruiting |
NCT04534868 -
Patient Acceptance And Satisfaction of Teledermoscopy In General Practice In a Belgian Rural Area
|
N/A | |
Recruiting |
NCT04138342 -
Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer
|
Phase 1 | |
Completed |
NCT03673917 -
Cosmetology Students and Skin Cancer
|
N/A | |
Recruiting |
NCT04341064 -
Sun-safe Habits Intervention and Education
|
Phase 3 | |
Completed |
NCT04206995 -
Cancer Sensing: Evaluation of Odour Sampling Techniques
|
||
Recruiting |
NCT05574101 -
A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer
|
Phase 2 | |
Not yet recruiting |
NCT05860881 -
Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients (SiroSkin)
|
Phase 3 | |
Completed |
NCT05146622 -
Virtual Sun Safe Workplaces Ph I
|
||
Recruiting |
NCT05068310 -
Applicability of a Cellular Resolution Full-field OCT Image System for Pigmented and Non-pigmented Skin Tumors
|
||
Recruiting |
NCT03889899 -
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
|
N/A |